本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

8.07
+0.17002.15%
成交量:140.15万
成交额:1,133.31万
市值:7.00亿
市盈率:-3.57
高:8.30
开:7.99
低:7.91
收:7.90
52周最高:21.57
52周最低:5.41
股本:8,679.72万
流通股本:6,398.56万
量比:0.93
换手率:2.19%
股息:- -
股息率:- -
每股收益(TTM):-2.2592
每股收益(LYR):-2.0193
净资产收益率:-51.11%
总资产收益率:-22.93%
市净率:2.29
市盈率(LYR):-4.00

数据加载中...

2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/02

重要事件披露

Form 8-K - Current report